Table 4-7: Results with fragrance contact allergy screening agents reported since 1999 in patients
patch tested for suspected allergic contact dermatitis: Myroxylon pereirae resin (Balsam of Peru)
(25% pet.). If not given in the publication, the confidence interval (CI) was calculated from the
absolute numbers by the SCCS (§).
Country (Ref.) |
Population |
Year(s) |
No. tested |
Crude % positive (95% CI)§ |
Tel Aviv, Israel (59) # |
Consecutive patients |
1999-2000 |
943 |
6.6
(5.1–8.4)§ |
South Korea (56) |
Consecutive patients |
04/2002 – 06/2003 |
422 |
7.3
(5.1–10.3)§ |
Tel Aviv, Israel (60) |
Consecutive patients |
1998-2004 |
2156 |
3.6
(2.9–4.5)§ |
Manipal, India (58) |
Dermatitis patients |
1989-1998 |
1780 |
1.0
(0.5 – 1.5) § |
Tehran, Iran (61) |
Consecutive patients |
2002-2004 |
250 |
2.4
(0.9–5.2)§ |
Sevilla, Spain (76) |
Consecutive patients |
2002-2004 |
863 |
5.8
(4.3–7.6)§ |
Ankara, Turkey (62) |
Consecutive patients |
1992-2004 |
1038 |
2.1
(1.3–3.2)§ |
Vienna, Austria (16) |
Consecutive patients of one clinic |
1997-2000 |
2660 |
5.4
(4.6–6.3)§ |
Czech Republic (40) |
Consecutive patients |
1997-2001 |
12058 |
7.3
(6.8–7.8)§ |
Spain (49) |
Consecutive patients |
10/2005-06/2008 |
1253 |
6.4
(5.1–7.9)§ |
Copenhagen, Denmark (52) |
Consecutive patients |
1985-2007 |
16173 |
3.9
(3.6–4.2)§ |
Sweden (38) |
Consecutive patients |
2000 |
3790 |
6.5 |
Nine European countries (53) |
Consecutive patients |
2002-2003 |
9672 |
6.1 |
Germany, three Swiss and one Austrian Dept. (43) |
Consecutive patients |
2005-2008 |
36919 |
8.0
(7.7–8.3) |
Ten depts. From seven EU countries (66) |
Consecutive patients |
1996-2000 |
26210 |
6.0 |
USA (Canada) (64) |
Probably consecutive patients |
2003 |
1603 |
6.6 |
NACDG 2009 (65) |
Consecutive patients |
2005-2006 |
4449 |
11.9 |
Source:
SCCS, Opinion on Fragrance allergens in cosmetic products, page 21-22
|